Sinai Hospital CyberKnife Center Upgrades to Latest Technology, Expands Treatment Options for Lung Cancer Patients
The CyberKnife Center at Sinai Hospital of Baltimore upgraded its cancer treatment technology to the next-generation CyberKnife® 9.0 system in early March.
CyberKnife is a robotic technology that performs stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation precisely aimed from different angles. The CyberKnife 9.0 features a device that controls the width of the machine’s radiation beam, allowing clinicians to vary the beam size and treat a larger variety of tumors throughout the body. The capabilities of the more advanced technology allow for greater accuracy, quicker treatment times for patients and better avoidance of healthy tissue during treatment.
“As the first in the region to establish a CyberKnife program, we aim to stay on the leading edge of cancer treatment,” said Jeanette Linder, M.D., chief of radiation oncology at the Alvin & Lois Lapidus Cancer Institute at Sinai Hospital of Baltimore. “The CyberKnife 9.0 is part of our commitment to ensure patients are treated with the most advanced technology available.”
In addition to increased efficiency, the CyberKnife 9.0 system offers Lung Optimization Treatment, or LOT, which allows lung cancer patients with conditions like emphysema or chronic obstructive pulmonary disease to undergo CyberKnife treatment without the use of fiducials – small metal markers – that are sometimes used to target the location of lung tumors during treatment. However, lung cancer patients already suffering from chronic lung disease may not be able to undergo the fiducial implantation process without increased risk of a collapsed lung.
The new CyberKnife technology featuring LOT reduces the need for placing fiducials in higher-risk lung tumor patients. Instead, the new technology uses cameras and medical imaging to determine in real time the tumor location and ensure the CyberKnife remains locked on target.
“LOT is a major advancement that opens CyberKnife treatment to more lung cancer patients who may not have previously been candidates due to other health issues,” explains Dr. Linder. “In some cases, patients with chronic pulmonary disease diagnosed with lung cancer have few alternatives for treatment.”
Over 1,800 patients have been treated at Sinai Hospital’s CyberKnife Center. The center is part of the Alvin & Lois Lapidus Cancer Institute at Sinai Hospital of Baltimore and is located at 2401 W. Belvedere Ave., Baltimore, Md. For more information, call (410) 601-9355 or visit the website.
Sinai Hospital is part of LifeBridge Health, one of the largest, most comprehensive providers of health services in northwest Baltimore. LifeBridge Health also includes Northwest Hospital, Levindale Hebrew Geriatric Center and Hospital, Courtland Gardens Nursing & Rehabilitation Center, and related subsidiaries and affiliates.